表紙：慢性静脈閉塞症治療の世界市場の規模：製品別、用途別、最終用途別、業界分析、地域の見通し、成長可能性、競合の市場シェア、予測（2022年～2030年）

市場調査レポート

商品コード

1157282

慢性静脈閉塞症治療の世界市場の規模：製品別、用途別、最終用途別、業界分析、地域の見通し、成長可能性、競合の市場シェア、予測（2022年～2030年）

Chronic Venous Occlusions Treatment Market Size by Product, By Application, By End-Use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030

出版日: 2022年11月15日 | 発行: Global Market Insights Inc.

| ページ情報: 英文 271 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel (Single User License)

USD 4,850 762,129円

レポートPDFおよびExcelを1名様のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Multi User License)

USD 5,350 840,699円

レポートPDFおよびExcelを5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Enterprise User License)

USD 8,350 1,312,119円

レポートPDFおよびExcelを同一企業内のすべての方にご利用頂けるライセンスです。 100％子会社は同一企業とみなされます。 PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の慢性静脈閉塞症治療の市場規模は、手術を必要とする慢性静脈閉塞症の流行により、2030年まで大きな収益を記録すると予測されています。

当レポートでは、世界の慢性静脈閉塞症治療市場について調査分析し、業界の考察、セグメント分析、地域分析、企業プロファイルなどを提供しています。

業界セグメンテーション
業界情勢（2017年～2030年）
業界の影響要因
- 成長促進要因
- 業界の潜在的リスク・課題
成長可能性分析
- 製品別
- 用途別
- 最終用途別
COVID-19の影響の分析
治療情勢
償還シナリオ
疫学シナリオ
ポーターのファイブフォース分析
競合情勢（2021年）
- 企業マトリックス分析（2021年）
PESTLE分析

第4章慢性静脈閉塞症治療市場：製品別

主なセグメントの動向
デバイス
- 市場規模：地域別（2017年～2030年）
- 圧縮デバイス
- 静脈内アブレーション
- 硬化療法
- 静脈ストリッパー
- その他
薬剤
- 市場規模：地域別（2017年～2030年）
- 鎮痛剤
- 抗生物質
- 抗凝固剤
- その他

第5章慢性静脈閉塞症治療市場：用途別

主なセグメントの動向
静脈瘤
静脈うっ血性潰瘍
浮腫
深部静脈血栓症
その他

第6章慢性静脈閉塞症治療市場：最終用途別

主なセグメントの動向
病院
外来手術センター
その他

第7章慢性静脈閉塞症治療市場：地域別

主な地域の動向
北米
- 市場規模：国別（2017年～2030年）
- 市場規模：製品別（2017年～2030年）
- 市場規模：用途別（2017年～2030年）
- 市場規模：最終用途別（2017年～2030年）
- 米国
- カナダ
欧州
- 市場規模：国別（2017年～2030年）
- 市場規模：製品別（2017年～2030年）
- 市場規模：用途別（2017年～2030年）
- 市場規模：最終用途別（2017年～2030年）
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
アジア太平洋
- 市場規模：国別（2017年～2030年）
- 市場規模：製品別（2017年～2030年）
- 市場規模：用途別（2017年～2030年）
- 市場規模：最終用途別（2017年～2030年）
- 中国
- 日本
- インド
- オーストラリア
- 韓国
ラテンアメリカ
- 市場規模：国別（2017年～2030年）
- 市場規模：製品別（2017年～2030年）
- 市場規模：用途別（2017年～2030年）
- 市場規模：最終用途別（2017年～2030年）
- ブラジル
- メキシコ
- アルゼンチン
中東・アフリカ
- 市場規模：国別（2017年～2030年）
- 市場規模：製品別（2017年～2030年）
- 市場規模：用途別（2017年～2030年）
- 市場規模：最終用途別（2017年～2030年）
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦

第8章企業プロファイル

競合ダッシュボード（2021年）
Boston Scientific Corporation
Stryker Corporation
AngioDynamics
Bristol Myers Squibb
Sanofi
Bayer AG
Medtronic plc
Pfizer Inc.
ISOMed
Cardinal Health
SerenaGroup
Tactile Medical
ArjoHuntleigh
Essity AB
Julius Zorn GmbH
Smith & Nephew PLC
Viatris Inc.
Merz Pharma
QOL Medical
Candela
Sciton, Inc
Fotona
3M Company
ConvaTec Inc.
Medi GmbH & Co. KG
Sigvaris AG
Leucadia Pharmaceuticals (Hikma)
Lumenis Ltd.
Venclose, Inc. (Becton Dickinson and Company

図表

Data Tables

TABLE 1 Global chronic venous occlusions treatment market, 2017 - 2021 (USD Million)
TABLE 2 Global chronic venous occlusions treatment market, 2022 - 2030 (USD Million)
TABLE 3 Global chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 4 Global chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 5 Global chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 6 Global chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 7 Global chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 8 Global chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 9 Global chronic venous occlusions treatment market, by region, 2017 - 2021 (USD Million)
TABLE 10 Global chronic venous occlusions treatment market, by region, 2022 - 2030 (USD Million)
TABLE 11 Industry impact forces
TABLE 12 Devices market, by region, 2017 - 2021, (USD Million)
TABLE 13 Devices market, by region, 2022 - 2030, (USD Million)
TABLE 14 Compression devices market, by region, 2017 - 2021, (USD Million)
TABLE 15 Compression devices market, by region, 2022 - 2030, (USD Million)
TABLE 16 Endovenous ablation market, by region, 2017 - 2021, (USD Million)
TABLE 17 Endovenous ablation systems market, by region, 2022 - 2030, (USD Million)
TABLE 18 Laser ablation market, by region, 2017 - 2021, (USD Million)
TABLE 19 Laser ablation market, by region, 2022 - 2030, (USD Million)
TABLE 20 Radiofrequency ablation market, by region, 2017 - 2021, (USD Million)
TABLE 21 Radiofrequency ablation market, by region, 2022 - 2030, (USD Million)
TABLE 22 Sclerotherapy market, by region, 2017 - 2021, (USD Million)
TABLE 23 Sclerotherapy market, by region, 2022 - 2030, (USD Million)
TABLE 24 Vein stripper market, by region, 2017 - 2021, (USD Million)
TABLE 25 Vein stripper market, by region, 2022 - 2030, (USD Million)
TABLE 26 Others market, by region, 2017 - 2021, (USD Million)
TABLE 27 Others market, by region, 2022 - 2030, (USD Million)
TABLE 28 Drugs market, by region, 2017 - 2021, (USD Million)
TABLE 29 Drugs market, by region, 2022 - 2030, (USD Million)
TABLE 30 Analgesics market, by region, 2017 - 2021, (USD Million)
TABLE 31 Analgesics market, by region, 2022 - 2030, (USD Million)
TABLE 32 Antibiotics market, by region, 2017 - 2021, (USD Million)
TABLE 33 Antibiotics market, by region, 2022 - 2030, (USD Million)
TABLE 34 Anticoagulants market, by region, 2017 - 2021, (USD Million)
TABLE 35 Anticoagulants market, by region, 2022 - 2030, (USD Million)
TABLE 36 Others market, by region, 2017 - 2021, (USD Million)
TABLE 37 Others market, by region, 2022 - 2030, (USD Million)
TABLE 38 Varicose veins market, by region, 2017 - 2021, (USD Million)
TABLE 39 Varicose veins market, by region, 2022 - 2030, (USD Million)
TABLE 40 Venous stasis ulcers market, by region, 2017 - 2021, (USD Million)
TABLE 41 Venous stasis ulcers market, by region, 2022 - 2030, (USD Million)
TABLE 42 Edema market, by region, 2017 - 2021, (USD Million)
TABLE 43 Edema market, by region, 2022 - 2030, (USD Million)
TABLE 44 Deep vein thrombosis market, by region, 2017 - 2021, (USD Million)
TABLE 45 Deep vein thrombosis market, by region, 2022 - 2030, (USD Million)
TABLE 46 Others market, by region, 2017 - 2021, (USD Million)
TABLE 47 Others market, by region, 2022 - 2030, (USD Million)
TABLE 48 Hospitals market, by region, 2017 - 2021, (USD Million)
TABLE 49 Hospitals market, by region, 2022 - 2030, (USD Million)
TABLE 50 Ambulatory surgical centers market, by region, 2017 - 2021, (USD Million)
TABLE 51 Ambulatory surgical centers market, by region, 2022 - 2030, (USD Million)
TABLE 52 Others market, by region, 2017 - 2021, (USD Million)
TABLE 53 Others market, by region, 2022 - 2030, (USD Million)
TABLE 54 North America chronic venous occlusions treatment market, by country, 2017 - 2021 (USD Million)
TABLE 55 North America chronic venous occlusions treatment market, by country, 2022 - 2030 (USD Million)
TABLE 56 North America chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 57 North America chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 58 North America chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 59 North America chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 60 North America chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 61 North America chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 62 North America chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 63 North America chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 64 North America chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 65 North America chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 66 North America chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 67 North America chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 68 U.S. chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 69 U.S. chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 70 U.S. chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 71 U.S. chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 72 U.S. chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 73 U.S. chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 74 U.S. chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 75 U.S. chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 76 U.S. chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 77 U.S. chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 78 U.S. chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 79 U.S. chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 80 Canada chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 81 Canada chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 82 Canada chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 83 Canada chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 84 Canada chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 85 Canada chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 86 Canada chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 87 Canada chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 88 Canada chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 89 Canada chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 90 Canada chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 91 Canada chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 92 Europe chronic venous occlusions treatment market, by country, 2017 - 2021 (USD Million)
TABLE 93 Europe chronic venous occlusions treatment market, by country, 2022 - 2030 (USD Million)
TABLE 94 Europe chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 95 Europe chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 96 Europe chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 97 Europe chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 98 Europe chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 99 Europe chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 100 Europe chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 101 Europe chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 102 Europe chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 103 Europe chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 104 Europe chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 105 Europe chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 106 Germany chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 107 Germany chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 108 Germany chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 109 Germany chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 110 Germany chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 111 Germany chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 112 Germany chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 113 Germany chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 114 Germany chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 115 Germany chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 116 Germany chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 117 Germany chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 118 UK chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 119 UK chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 120 UK chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 121 UK chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 122 UK chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 123 UK chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 124 UK chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 125 UK chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 126 UK chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 127 UK chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 128 UK chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 129 UK chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 130 France chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 131 France chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 132 France chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 133 France chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 134 France chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 135 France chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 136 France chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 137 France chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 138 France chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 139 France chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 140 France chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 141 France chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 142 Spain chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 143 Spain chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 144 Spain chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 145 Spain chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 146 Spain chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 147 Spain chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 148 Spain chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 149 Spain chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 150 Spain chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 151 Spain chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 152 Spain chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 153 Spain chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 154 Italy chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 155 Italy chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 156 Italy chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 157 Italy chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 158 Italy chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 159 Italy chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 160 Italy chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 161 Italy chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 162 Italy chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 163 Italy chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 164 Italy chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 165 Italy chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 166 Asia Pacific chronic venous occlusions treatment market, by country, 2017 - 2021 (USD Million)
TABLE 167 Asia Pacific chronic venous occlusions treatment market, by country, 2022 - 2030 (USD Million)
TABLE 168 Asia Pacific chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 169 Asia Pacific chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 170 Asia Pacific chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 171 Asia Pacific chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 172 Asia Pacific chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 173 Asia Pacific chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 174 Asia Pacific chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 175 Asia Pacific chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 176 Asia Pacific chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 177 Asia Pacific chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 178 Asia Pacific chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 179 Asia Pacific chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 180 China chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 181 China chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 182 China chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 183 China chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 184 China chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 185 China chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 186 China chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 187 China chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 188 China chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 189 China chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 190 China chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 191 China chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 192 Japan chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 193 Japan chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 194 Japan chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 195 Japan chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 196 Japan chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 197 Japan chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 198 Japan chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 199 Japan chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 200 Japan chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 201 Japan chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 202 Japan chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 203 Japan chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 204 India chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 205 India chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 206 India chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 207 India chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 208 India chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 209 India chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 210 India chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 211 India chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 212 India chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 213 India chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 214 India chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 215 India chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 216 Australia chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 217 Australia chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 218 Australia chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 219 Australia chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 220 Australia chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 221 Australia chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 222 Australia chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 223 Australia chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 224 Australia chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 225 Australia chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 226 Australia chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 227 Australia chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 228 South Korea chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 229 South Korea chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 230 South Korea chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 231 South Korea chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 232 South Korea chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 233 South Korea chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 234 South Korea chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 235 South Korea chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 236 South Korea chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 237 South Korea chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 238 South Korea chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 239 South Korea chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 240 Latin America chronic venous occlusions treatment market, by country, 2017 - 2021 (USD Million)
TABLE 241 Latin America chronic venous occlusions treatment market, by country, 2022 - 2030 (USD Million)
TABLE 242 Latin America chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 243 Latin America chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 244 Latin America chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 245 Latin America chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 246 Latin America chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 247 Latin America chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 248 Latin America chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 249 Latin America chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 250 Latin America chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 251 Latin America chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 252 Latin America chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 253 Latin America chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 254 Brazil chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 255 Brazil chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 256 Brazil chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 257 Brazil chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 258 Brazil chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 259 Brazil chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 260 Brazil chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 261 Brazil chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 262 Brazil chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 263 Brazil chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 264 Brazil chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 265 Brazil chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 266 Mexico chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 267 Mexico chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 268 Mexico chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 269 Mexico chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 270 Mexico chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 271 Mexico chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 272 Mexico chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 273 Mexico chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 274 Mexico chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 275 Mexico chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 276 Mexico chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 277 Mexico chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 278 Argentina chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 279 Argentina chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 280 Argentina chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 281 Argentina chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 282 Argentina chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 283 Argentina chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 284 Argentina chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 285 Argentina chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 286 Argentina chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 287 Argentina chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 288 Argentina chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 289 Argentina chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 290 MEA chronic venous occlusions treatment market, by country, 2017 - 2021 (USD Million)
TABLE 291 MEA chronic venous occlusions treatment market, by country, 2022 - 2030 (USD Million)
TABLE 292 MEA chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 293 MEA chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 294 MEA chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 295 MEA chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 296 MEA chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 297 MEA chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 298 MEA chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 299 MEA chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 300 MEA chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 301 MEA chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 302 MEA chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 303 MEA chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 304 South Africa chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 305 South Africa chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 306 South Africa chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 307 South Africa chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 308 South Africa chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 309 South Africa chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 310 South Africa chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 311 South Africa chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 312 South Africa chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 313 South Africa chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 314 South Africa chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 315 South Africa chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 316 Saudi Arabia chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 317 Saudi Arabia chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 318 Saudi Arabia chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 319 Saudi Arabia chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 320 Saudi Arabia chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 321 Saudi Arabia chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 322 Saudi Arabia chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 323 Saudi Arabia chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 324 Saudi Arabia chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 325 Saudi Arabia chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 326 Saudi Arabia chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 327 Saudi Arabia chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
TABLE 328 UAE chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
TABLE 329 UAE chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
TABLE 330 UAE chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
TABLE 331 UAE chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
TABLE 332 UAE chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
TABLE 333 UAE chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
TABLE 334 UAE chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
TABLE 335 UAE chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
TABLE 336 UAE chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
TABLE 337 UAE chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
TABLE 338 UAE chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
TABLE 339 UAE chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)

Charts & Figures

FIG. 1 Top-down approach
FIG. 2 Breakdown of primary participants
FIG. 3 Chronic venous occlusion treatment industry 360 degree synopsis, 2017 - 2030
FIG. 4 Industry segmentation
FIG. 5 Global chronic venous occlusion treatment market, 2017 - 2030 (USD Million)
FIG. 6 Growth potential analysis, by product
FIG. 7 Growth potential analysis, by application
FIG. 8 Growth potential analysis, by end-use
FIG. 9 Porter's Analysis
FIG. 10 Company matrix analysis, 2021
FIG. 11 PESTEL Analysis
FIG. 12 Key segment trends, by product
FIG. 13 Key segment trends, by application
FIG. 14 Key segment trends, by end-use
FIG. 15 Key regional trends
FIG. 16 Strategy dashboard, 2021

Product Code: 5398

Global Chronic Venous Occlusions Treatment Market share is foreseen to record significant proceeds through 2030 owing to the growing prevalence of chronic venous occlusion ailments that require surgical attention. As per orpha.net statistics, hepatic veno-occlusive disease develops in 0.3 per cent to 2.3 per cent of patients who receive liver transplant, in 15% of patients treated with gemtuzumab ozogamicin, with statistics projected to rise to 40% in those with a history of GO treatment.

Factors like ongoing research studies and technological developments in deep vein thrombosis treatment would contribute to the growing market landscape between 2022-2030. In 2021, Penn State College of Engineering researchers developed an imaging technique that could become the treatment for deep vein thrombosis.

The overall market is segmented into products, applications, end-use, and regions.

Based on the product bifurcation, the devices segment is likely to amass substantial gains over 2022-2030. Mounting demand for advanced therapeutic and medical devices on grounds of their multiple advantages would contribute to the segmental expansion. Besides, the use of chronic venous occlusions treatment devices aids in controlling and preventing blood clots while increasing blood flow in legs.

In terms of application, chronic venous occlusions treatment market share from varicose veins segment is slated to surge considerably by 2030 end. Rising prevalence of varicose veins worldwide would prompt the product demand. Globally, the frequency varies between 10% to 30% of the population. Meanwhile, in the US, the prevalence is around 4,500 in 100,000 people. Numerous merits offered by the available treatment alternatives for chronic venous occlusion in treatment of varicose veins would stimulate the market prospects.

On basis of end-use, the hospitals segment is observing positive growth in the global market due to the rising adoption of technologically advanced venous devices and the availability of minimally invasive treatment options. Furthermore, the presence of medical professionals with high expertise and skills in target disorder treatment would complement the chronic venous occlusions treatment market growth trajectory between 2022-2030.

Geographically, North America chronic venous occlusions treatment market size is predicted to rise meteorically. In 2021, the regional market captured a more than 40% business share and would expand further at a notable rate through 2030. The growth would come from the elevating prevalence of chronic venous diseases, presence of major players in the continent, and reimbursement medical policies across North America.

The chronic venous occlusions treatment industry is highly consolidated and boasts presence of leading companies such as Sanofi, Boston Scientific Corporation, Bayer AG, Stryker Corporation, Bristol Myers Squibb, Cardinal Health, Tactile Medical, Pfizer Inc., and Medtronic plc, amongst others. These conglomerates are engaged in business tactics including acquisitions, mergers, partnerships, and product launches to gain a competitive advantage over others.

Chapter 1 Methodology & Scope

1.1 Market definitions
1.2 Base estimates and working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
- 1.5.1 Secondary
  - 1.5.1.1 Paid sources
  - 1.5.1.2 Unpaid sources
- 1.5.2 Primary

Chapter 2 Executive Summary

2.1 Chronic venous occlusions treatment industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Application trends
- 2.1.4 End-use trends
- 2.1.5 Regional trends

Chapter 3 Chronic Venous Occlusions Treatment Industry Insights

3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030 (USD Million)
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Increasing prevalence of varicose veins coupled with rising awareness regarding its treatment
  - 3.3.1.2 Growing preference for minimally invasive procedures
  - 3.3.1.3 Rise in number of orthopedic procedures
  - 3.3.1.4 Technological advancements pertaining to chronic venous insufficiency treatment therapies
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Side effects and risks associated with different treatment modes
  - 3.3.2.2 Strict regulatory guidelines
3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By application
- 3.4.3 By end-use
3.5 COVID- 19 impact analysis
3.6 Treatment landscape
3.7 Reimbursement scenario
3.8 Epidemiology scenario
3.9 Porter's analysis
- 3.9.1 Industry rivalry
- 3.9.2 Suppliers power
- 3.9.3 Buyer power
- 3.9.4 Threat of substitute
- 3.9.5 Threat of new entrants
3.10 Competitive landscape, 2021
- 3.10.1 Company matrix analysis, 2021
3.11 PESTLE analysis
- 3.11.1 Political
- 3.11.2 Economical
- 3.11.3 Social
- 3.11.4 Technological
- 3.11.5 Legal
- 3.11.6 Environmental

Chapter 4 Chronic Venous Occlusions Treatment Market, By Product

4.1 Key segment trends
4.2 Devices
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.2 Compression Devices
  - 4.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.3 Endovenous Ablation
  - 4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
  - 4.2.3.2 Laser Ablation
    - 4.2.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
  - 4.2.3.3 Radiofrequency Ablation
    - 4.2.3.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.4 Sclerotherapy
  - 4.2.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.5 Vein stripper
  - 4.2.5.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.6 Others
  - 4.2.6.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Drugs
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3.2 Analgesics
  - 4.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3.3 Antibiotics
  - 4.3.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3.4 Anticoagulants
  - 4.3.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3.5 Others
  - 4.3.5.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Chronic Venous Occlusions Treatment Market, By Application

5.1 Key segment trends
5.2 Varicose Veins
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
5.3 Venous Stasis Ulcers
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
5.4 Edema
- 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
5.5 Deep Vein Thrombosis
- 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
5.6 Others
- 5.6.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Chronic Venous Occlusions Treatment Market, By End-use

6.1 Key segment trends
6.2 Hospitals
- 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
6.3 Ambulatory surgical centers
- 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
6.4 Others
- 6.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 7 Chronic Venous Occlusions Treatment Market, By Region

7.1 Key regional trends
7.2 North America
- 7.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.2.2 Market size, by product, 2017 - 2030 (USD Million)
  - 7.2.2.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.2.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
  - 7.2.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.2.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.2.5 U.S.
  - 7.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.2.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.2.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.2.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.2.5.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.2.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.2.6 Canada
  - 7.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.2.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.2.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.2.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.2.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.3 Europe
- 7.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.3.2 Market size, by product, 2017 - 2030 (USD Million)
  - 7.3.2.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.3.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
  - 7.3.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.3.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.5 Germany
  - 7.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.3.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.3.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.3.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.3.5.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.3.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.6 UK
  - 7.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.3.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.3.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.3.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.3.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.7 France
  - 7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.3.7.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.3.7.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.3.7.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.3.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.8 Spain
  - 7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.3.8.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.3.8.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.3.8.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.3.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.9 Italy
  - 7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.3.9.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.3.9.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.3.9.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.3.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.4 Asia Pacific
- 7.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.4.2 Market size, by product, 2017 - 2030 (USD Million)
  - 7.4.2.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.4.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
  - 7.4.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.4.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.5 China
  - 7.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.4.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.4.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.4.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.4.5.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.4.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.6 Japan
  - 7.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.4.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.4.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.4.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.4.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.7 India
  - 7.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.4.7.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.4.7.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.4.7.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.4.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.8 Australia
  - 7.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.4.8.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.4.8.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.4.8.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.4.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.9 South Korea
  - 7.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.4.9.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.4.9.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.4.9.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.4.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.5 Latin America
- 7.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.5.2 Market size, by product, 2017 - 2030 (USD Million)
  - 7.5.2.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.5.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
  - 7.5.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.5.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.5 Brazil
  - 7.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.5.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.5.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.5.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.5.5.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.5.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.6 Mexico
  - 7.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.5.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.5.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.5.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.5.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.7 Argentina
  - 7.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.5.7.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.5.7.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.5.7.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.5.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.6 MEA
- 7.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.6.2 Market size, by product, 2017 - 2030 (USD Million)
  - 7.6.2.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.6.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
  - 7.6.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.6.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.5 South Africa
  - 7.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.6.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.6.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.6.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.6.5.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.6.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.6 Saudi Arabia
  - 7.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.6.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.6.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.6.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.7 UAE
  - 7.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.6.7.1.1 Market size, by devices, 2017 - 2030 (USD Million)
    - 7.6.7.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
    - 7.6.7.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
  - 7.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
  - 7.6.7.3 Market size, by end-use, 2017 - 2030 (USD Million)

Chapter 8 Company Profiles

8.1 Competitive dashboard, 2021
8.2 Boston Scientific Corporation
- 8.2.1 Business Overview
- 8.2.2 Financial Data
- 8.2.3 Product Landscape
- 8.2.4 Strategic Outlook
- 8.2.5 SWOT Analysis
8.3 Stryker Corporation
- 8.3.1 Business Overview
- 8.3.2 Financial Data
- 8.3.3 Product Landscape
- 8.3.4 Strategic Outlook
- 8.3.5 SWOT Analysis
8.4 AngioDynamics
- 8.4.1 Business Overview
- 8.4.2 Financial Data
- 8.4.3 Product Landscape
- 8.4.4 Strategic Outlook
- 8.4.5 SWOT Analysis
8.5 Bristol Myers Squibb
- 8.5.1 Business Overview
- 8.5.2 Financial Data
- 8.5.3 Product Landscape
- 8.5.4 Strategic Outlook
- 8.5.5 SWOT Analysis
8.6 Sanofi
- 8.6.1 Business Overview
- 8.6.2 Financial Data
- 8.6.3 Product Landscape
- 8.6.4 Strategic Outlook
- 8.6.5 SWOT Analysis
8.7 Bayer AG
- 8.7.1 Business Overview
- 8.7.2 Financial Data
- 8.7.3 Product Landscape
- 8.7.4 Strategic Outlook
- 8.7.5 SWOT Analysis
8.8 Medtronic plc
- 8.8.1 Business Overview
- 8.8.2 Financial Data
- 8.8.3 Product Landscape
- 8.8.4 Strategic Outlook
- 8.8.5 SWOT Analysis
8.9 Pfizer Inc.
- 8.9.1 Business Overview
- 8.9.2 Financial Data
- 8.9.3 Product Landscape
- 8.9.4 Strategic Outlook
- 8.9.5 SWOT Analysis
8.10 ISOMed
- 8.10.1 Business Overview
- 8.10.2 Financial Data
- 8.10.3 Product Landscape
- 8.10.4 Strategic Outlook
- 8.10.5 SWOT Analysis
8.11 Cardinal Health
- 8.11.1 Business Overview
- 8.11.2 Financial Data
- 8.11.3 Product Landscape
- 8.11.4 Strategic Outlook
- 8.11.5 SWOT Analysis
8.12 SerenaGroup
- 8.12.1 Business Overview
- 8.12.2 Financial Data
- 8.12.3 Product Landscape
- 8.12.4 Strategic Outlook
- 8.12.5 SWOT Analysis
8.13 Tactile Medical
- 8.13.1 Business Overview
- 8.13.2 Financial Data
- 8.13.3 Product Landscape
- 8.13.4 Strategic Outlook
- 8.13.5 SWOT Analysis
8.14 ArjoHuntleigh
- 8.14.1 Business Overview
- 8.14.2 Financial Data
- 8.14.3 Product Landscape
- 8.14.4 Strategic Outlook
- 8.14.5 SWOT Analysis
8.15 Essity AB
- 8.15.1 Business Overview
- 8.15.2 Financial Data
- 8.15.3 Product Landscape
- 8.15.4 Strategic Outlook
- 8.15.5 SWOT Analysis
8.16 Julius Zorn GmbH
- 8.16.1 Business Overview
- 8.16.2 Financial Data
- 8.16.3 Product Landscape
- 8.16.4 Strategic Outlook
- 8.16.5 SWOT Analysis
8.17 Smith & Nephew PLC
- 8.17.1 Business Overview
- 8.17.2 Financial Data
- 8.17.3 Product Landscape
- 8.17.4 Strategic Outlook
- 8.17.5 SWOT Analysis
8.18 Viatris Inc.
- 8.18.1 Business Overview
- 8.18.2 Financial Data
- 8.18.3 Product Landscape
- 8.18.4 Strategic Outlook
- 8.18.5 SWOT Analysis
8.19 Merz Pharma
- 8.19.1 Business Overview
- 8.19.2 Financial Data
- 8.19.3 Product Landscape
- 8.19.4 Strategic Outlook
- 8.19.5 SWOT Analysis
8.20 QOL Medical
- 8.20.1 Business Overview
- 8.20.2 Financial Data
- 8.20.3 Product Landscape
- 8.20.4 Strategic Outlook
- 8.20.5 SWOT Analysis
8.21 Candela
- 8.21.1 Business Overview
- 8.21.2 Financial Data
- 8.21.3 Product Landscape
- 8.21.4 Strategic Outlook
- 8.21.5 SWOT Analysis
8.22 Sciton, Inc
- 8.22.1 Business Overview
- 8.22.2 Financial Data
- 8.22.3 Product Landscape
- 8.22.4 Strategic Outlook
- 8.22.5 SWOT Analysis
8.23 Fotona
- 8.23.1 Business Overview
- 8.23.2 Financial Data
- 8.23.3 Product Landscape
- 8.23.4 Strategic Outlook
- 8.23.5 SWOT Analysis
8.24 3M Company
- 8.24.1 Business Overview
- 8.24.2 Financial Data
- 8.24.3 Product Landscape
- 8.24.4 Strategic Outlook
- 8.24.5 SWOT Analysis
8.25 ConvaTec Inc.
- 8.25.1 Business Overview
- 8.25.2 Financial Data
- 8.25.3 Product Landscape
- 8.25.4 Strategic Outlook
- 8.25.5 SWOT Analysis
8.26 Medi GmbH & Co. KG
- 8.26.1 Business Overview
- 8.26.2 Financial Data
- 8.26.3 Product Landscape
- 8.26.4 Strategic Outlook
- 8.26.5 SWOT Analysis
8.27 Sigvaris AG
- 8.27.1 Business Overview
- 8.27.2 Financial Data
- 8.27.3 Product Landscape
- 8.27.4 Strategic Outlook
- 8.27.5 SWOT Analysis
8.28 Leucadia Pharmaceuticals (Hikma)
- 8.28.1 Business Overview
- 8.28.2 Financial Data
- 8.28.3 Product Landscape
- 8.28.4 Strategic Outlook
- 8.28.5 SWOT Analysis
8.29 Lumenis Ltd.
- 8.29.1 Business Overview
- 8.29.2 Financial Data
- 8.29.3 Product Landscape
- 8.29.4 Strategic Outlook
- 8.29.5 SWOT Analysis
8.30 Venclose, Inc. (Becton Dickinson and Company
- 8.30.1 Business Overview
- 8.30.2 Financial Data
- 8.30.3 Product Landscape
- 8.30.4 Strategic Outlook
- 8.30.5 SWOT Analysis

慢性静脈閉塞症治療の世界市場の規模：製品別、用途別、最終用途別、業界分析、地域の見通し、成長可能性、競合の市場シェア、予測（2022年～2030年）

Chronic Venous Occlusions Treatment Market Size by Product, By Application, By End-Use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章慢性静脈閉塞症治療業界の考察

第4章慢性静脈閉塞症治療市場：製品別

第5章慢性静脈閉塞症治療市場：用途別

第6章慢性静脈閉塞症治療市場：最終用途別

第7章慢性静脈閉塞症治療市場：地域別

第8章企業プロファイル

Data Tables

Charts & Figures

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Chronic Venous Occlusions Treatment Industry Insights

Chapter 4 Chronic Venous Occlusions Treatment Market, By Product

Chapter 5 Chronic Venous Occlusions Treatment Market, By Application

Chapter 6 Chronic Venous Occlusions Treatment Market, By End-use

Chapter 7 Chronic Venous Occlusions Treatment Market, By Region

Chapter 8 Company Profiles

慢性静脈閉塞症治療の世界市場の規模：製品別、用途別、最終用途別、業界分析、地域の見通し、成長可能性、競合の市場シェア、予測（2022年～2030年）

Chronic Venous Occlusions Treatment Market Size by Product, By Application, By End-Use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 慢性静脈閉塞症治療業界の考察

第4章 慢性静脈閉塞症治療市場：製品別

第5章 慢性静脈閉塞症治療市場：用途別

第6章 慢性静脈閉塞症治療市場：最終用途別

第7章 慢性静脈閉塞症治療市場：地域別

第8章 企業プロファイル

Data Tables

Charts & Figures

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Chronic Venous Occlusions Treatment Industry Insights

Chapter 4 Chronic Venous Occlusions Treatment Market, By Product

Chapter 5 Chronic Venous Occlusions Treatment Market, By Application

Chapter 6 Chronic Venous Occlusions Treatment Market, By End-use

Chapter 7 Chronic Venous Occlusions Treatment Market, By Region

Chapter 8 Company Profiles

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章慢性静脈閉塞症治療業界の考察

第4章慢性静脈閉塞症治療市場：製品別

第5章慢性静脈閉塞症治療市場：用途別

第6章慢性静脈閉塞症治療市場：最終用途別

第7章慢性静脈閉塞症治療市場：地域別

第8章企業プロファイル